Abstract
A basal cell carcinoma (BCC) cell line (BCC-1/KMC) has recently been successfully established from a patient. The production of interleukin-1α (IL-1α), IL-1β, IL-6 and IL-8 was assessed in comparison with that of cultured normal keratinocytes. The mRNA expression of these cytokines was measured by a reverse transcriptase-polymerase chain reaction (RT-PCR) method and the protein production by an ELISA. The cultured BCC cells spontaneously secreted more IL-6 and IL-8 but less IL-1 than the keratinocytes after culture for 24 h at 37°C. It is suggested that the increased expression of IL-6 and IL-8 may indicate the transformation of normal keratinocytes to locally aggressive BCC.
Similar content being viewed by others
References
Weinstein GC, Frost P (1970) Cell proliferation in human basal cell carcinoma. Cancer Res 30:724–728
Grimwood RE, Siegle RJ, Ferris CF (1986) The biology of basal cell carcinomas—a revisit and recent developments. J Dermatol Surg Oncol 12:805–808
Chiang LC, Chiang W, Yu HS, Sheu HM, Chen HY (1994) Establishment and characterization of a continuous human basal cell carcinoma cell line from facial skin (I) cytological behavior of early passages. Kaohsiung J Med Sci 10:170–176
Shimada S, Katz S (1988) The skin as an immunologic organ. Arch Pathol Lab Med 112:231–234
Kupper TS (1988) Interleukin 1 and other human keratinocyte cytokines: molecular and functional characterization. Adv Dermatol 3:293–301
Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367–6371
Neuner P, Urbanski A, Trautinger F, Moller A, Kirnbauer R, Kapp A, Schopf E, Schwarz T, Luger TA (1991) Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 97:27–33
Partridge M, Chantry D, Turner M, Feldmann M (1991) Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines. J Invest Dermatol 96:771–776
Abruzzo LV, Thornton AJ, Liebert M, Grossman B, Evanoff H, Westwick J, Strieter RM, Kunkel SL (1992) Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. Am J Pathol 140: 365–373
Shigh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ (1994) Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 54:3242–3247
Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151:2667–2675
Goslen JB, Bauer EA (1986) Basal cell carcinoma and collagenase. J Dermatol Surg Oncol 12:812–817
Hernandez AD, Hibbs MS, Postlethwaite AE (1985) Establishment of basal cell carcinoma in culture: evidence for a basal cell carcinoma-derived factor(s) which stimulates fibroblasts to proliferate and release collagenase. J Invest Dermatol 85:471–475
Yamamura M, Modlin RL, Ohmen JD, Moy RL (1993) Local expression of antiinflammatory cytokines in cancer. J Clin Invest 91:1005–1010
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Sambrook J, Maniatis T, Fristsch EF (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 8.1–8.13
Brenner CA, Tam AW, Nelson PA, Engleman EG, Suzuki N, Fry KE, Larrick JW (1989) Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small number of cells. Biotechnology 7:1096–1103
Paludan K, Thestrup-Pedersen K (1992) Use of the polymerase chain reaction in quantification of interleukin 8 mRNA in minute epidermal samples. J Invest Dermatol 99:830–835
Brossart P, Keiholz U, Willhauck M, Scheibenbogen C, Mohler T, Hunstein W (1993) Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101:887–889
Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S (1990) Cytokine modulation of keratinocyte cytokines. Invest Dermatol 94:101S-107S
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767
Hill ADK, Redmond HP, Croke DT, Grace PA, Bouchier-Hayes D (1992) Cytokines in tumour therapy. Br J Surg 79: 990–997
Dinarello CA (1989) Interleukin-1 and its biologically related cytokines. Adv Immunol 44:153–205
Nozaki S, Feliciani C, Sauder DN (1991) Keratinocyte cytokines. Adv Dermatol 7:83–101
Mizutani H, Black R, Kupper T (1989) Post-translation modifications of IL-1 differ markedly in keratinocytes and monocytes: implications for epidermal biology. J Invest Dermatol 92: 483A
Chua CC, Geiman DE, Keller GH, Ladda RL (1985) Induction of collagenase secretion in human fibroblast cultures by growth promoting factors. J Biol Chem 260:5213–5216
Duncan MR, Derman B (1991) Stimulation of collagen and glykosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 97:686–692
Wlaschek M, Bolsen K, Herrmann G, Scharz A, Wilmroth F, Heinrich PC, Goerz G, Scharffetter-Kochanek K (1993) UVA-induced autocrine stimulation of fibroblast-derived-collagenase by IL-6: a possible mechanism in dermal photodamage. J Invest Dermatol 101:164–168
Sehgal PB (1990) Interleukin-6: molecular pathophysiology. J Invest Dermatol 94:2S-6S
Luger TA, Schwarz T, Krutman J, Kirnbauer R, Neuner P, Kock A, Urbanski A, Borth W, Schauer E (1989) Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells. Ann NY Acad Sci 557:405–414
Kupper TS, Min K, Sehgal PB, Mizutani H, Birchall N, Ray A, May L (1989) Production of IL-6 by keratinocytes: implications for epidermal inflammation and immunity. Ann. NY Acad Sci 557:454–464
Shaw G, Kamen R (1986) A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667
Peppel K, Vinci JM, Baglioni C (1991) The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 173: 349–355
Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265:621–626
Zhang XG, Klein B, Bataille R (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 74:11–13
Kishimoto T (1989) The biology of interleukin-6. Blood 74: 1–10
Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G (1991) Upper keratinocytes of psoriatic skin lesions express high levels of NAP-2/IL-8 mRNA in situ. J Invest Dermatol 97: 73–79
Kenneney L, Ruzicka T, Dobozy A, Michel G (1994) Role of interleukin-8 receptor in skin. Int Arch Allergy Immunol 104: 317–322
Hirose K, Hakozaki M, Nyunoya Y, Kobayashi Y, Matsushita K, Takenouchi T, Mikata A, Mukaida N, Matsushima K (1995) Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer 72:708–714
Wang JM, Taraboletti G, Matsushima K, Damme JV, Mantovani A (1990) Induction of hapatotactic migration of melanoma cells by neutrophil activating protein/IL-8. Biochem Biophys Res Commun 160:165–170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yen, HT., Chiang, LC., Wen, KH. et al. The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch Dermatol Res 288, 157–161 (1996). https://doi.org/10.1007/BF02505826
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02505826